KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Gains from Investment Securities (2016 - 2025)

Opko Health (OPK) has disclosed Gains from Investment Securities for 14 consecutive years, with $2.1 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Gains from Investment Securities changed N/A year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Mar 2025, up 501.36%, and an annual FY2025 reading of $63000.0, changed N/A over the prior year.
  • Gains from Investment Securities was $2.1 million for Q1 2025 at Opko Health, up from $525000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $15.4 million in Q2 2022 and bottomed at -$5.5 million in Q4 2021.
  • Average Gains from Investment Securities over 4 years is $1.2 million, with a median of $477000.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities crashed 146.27% in 2021, then skyrocketed 112.43% in 2022.
  • Year by year, Gains from Investment Securities stood at -$5.5 million in 2021, then surged by 112.43% to $685000.0 in 2022, then fell by 23.36% to $525000.0 in 2023, then soared by 292.19% to $2.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for OPK at $2.1 million in Q1 2025, $525000.0 in Q4 2023, and -$1.0 million in Q3 2023.